4wem
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | ''' | + | ==Co-complex structure of the F4 fimbrial adhesin FaeG variant ac with llama single domain antibody V1== |
+ | <StructureSection load='4wem' size='340' side='right' caption='[[4wem]], [[Resolution|resolution]] 1.55Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[4wem]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4WEM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4WEM FirstGlance]. <br> | ||
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | ||
+ | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3hlr|3hlr]]</td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4wem FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4wem OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4wem RCSB], [http://www.ebi.ac.uk/pdbsum/4wem PDBsum]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Oral feed-based passive immunization can be a promising strategy to prolong maternal lactogenic immunity against postweaning infections. Enterotoxigenic Escherichia coli (ETEC)-caused postweaning diarrhea in piglets is one such infection that may be prevented by oral passive immunization and might avert recurrent economic losses to the pig farming industry. As a proof of principle, we designed anti-ETEC antibodies by fusing variable domains of llama heavy chain-only antibodies (VHHs) against ETEC to the Fc part of a porcine immunoglobulin (IgG or IgA) and expressed them in Arabidopsis thaliana seeds. In this way, four VHH-IgG and four VHH-IgA antibodies were produced to levels of about 3% and 0.2% of seed weight, respectively. Cotransformation of VHH-IgA with the porcine joining chain and secretory component led to the production of light-chain devoid, assembled multivalent dimeric, and secretory IgA-like antibodies. In vitro analysis of all of the antibody-producing seed extracts showed inhibition of bacterial binding to porcine gut villous enterocytes. However, in the piglet feed-challenge experiment, only the piglets receiving feed containing the VHH-IgA-based antibodies (dose 20 mg/d per pig) were protected. Piglets receiving the VHH-IgA-based antibodies in the feed showed a progressive decline in shedding of bacteria, significantly lower immune responses corroborating reduced exposure to the ETEC pathogen, and a significantly higher weight gain compared with the piglets receiving VHH-IgG producing (dose 80 mg/d per pig) or wild-type seeds. These results stress the importance of the antibody format in oral passive immunization and encourage future expression of these antibodies in crop seeds. | ||
- | + | Orally fed seeds producing designer IgAs protect weaned piglets against enterotoxigenic Escherichia coli infection.,Virdi V, Coddens A, De Buck S, Millet S, Goddeeris BM, Cox E, De Greve H, Depicker A Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11809-14. doi:, 10.1073/pnas.1301975110. Epub 2013 Jun 25. PMID:23801763<ref>PMID:23801763</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | + | </div> | |
- | + | == References == | |
- | [[Category: | + | <references/> |
- | [[Category: | + | __TOC__ |
- | [[Category: | + | </StructureSection> |
+ | [[Category: Broeck, I Van den]] | ||
+ | [[Category: Greve, H De]] | ||
+ | [[Category: Kerpel, M De]] | ||
+ | [[Category: Moonens, K]] | ||
+ | [[Category: Pardon, E]] | ||
[[Category: Remaut, H]] | [[Category: Remaut, H]] | ||
- | [[Category: | + | [[Category: Adhesin]] |
- | [[Category: | + | [[Category: Complex]] |
- | [[Category: | + | [[Category: Llama single domain antibody]] |
+ | [[Category: Nanobody]] | ||
+ | [[Category: Structural protein]] |
Revision as of 15:51, 7 February 2015
Co-complex structure of the F4 fimbrial adhesin FaeG variant ac with llama single domain antibody V1
|